Povidone Iodine Ointment
NDC Package 69396-112-20
Package Information
Povidone Iodine (povidone iodine 10%) ointment is clean the affected area apply a small amount of this product (equal to the surface area of a fingertip) to the area 1 to 3 times daily.may be covered with a sterile bandage. This formulation utilizes a ointment delivery system. Marketed by Trifecta Pharmaceuticals Usa Llc, this product is identified by NDC 69396-112 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 312563 - povidone-iodine 10 % Topical Ointment
- RxCUI: 312563 - povidone-iodine 0.1 MG/MG Topical Ointment
- RxCUI: 312563 - povidone-iodine 10 % (equal to 1 % available iodine) Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69396 - Trifecta Pharmaceuticals Usa Llc
- 69396-112 - Povidone Iodine
- 69396-112-20 - 1 TUBE in 1 BOX / 28.3 g in 1 TUBE
- 69396-112 - Povidone Iodine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69396-112-20 identifies a specific commercial package of 1 tube in 1 box / 28.3 g in 1 tube of Povidone Iodine, a human over the counter drug labeled by Trifecta Pharmaceuticals Usa Llc. This ointment is formulated for topical use and contains povidone-iodine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Trifecta Pharmaceuticals Usa Llc on December 23, 2022. The current certification is valid through December 31, 2026.
How is this Trifecta Pharmaceuticals Usa Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69396011220. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.